Holland & Knight Surges to Top of M&A and Private Equity League Table Rankings for 2023
NEW YORK (January 17, 2024) – Holland & Knight has been recognized as a top-ranked law firm for mergers and acquisitions (M&A) and private equity transactions for 2023 in benchmarking league tables published by Bloomberg and LSEG (formerly Refinitiv). The firm landed in the top five in the United States and top 10 globally, by deal count, for all M&A and private equity transactions, and in the top five for mid-market deals in the U.S.
In recent years, Holland & Knight has emerged as a dominant law firm for middle-market transactions as a result of its rapid growth, industry-specific knowledge, and innovative and personalized client service strategies. For example, through the HK Deal Flow℠ program, Holland & Knight facilitates deal leads for clients and prospective clients by matching acquisition or capital raising opportunities with buyers and investors.
The league table results reflect Holland & Knight's emphasis on growing its M&A and private equity practices in the U.S. and Latin America as well as its strength in industry sectors such as healthcare, energy, technology and transportation.
Some highlights of the 2023 league table rankings include:
LSEG (formerly Refinitiv) – Global M&A
- 4th – U.S. Target Completed
- 7th – U.S. Any Involvement Completed
- 7th – Global Principal Advisors Completed
- 7th – Global Completed
LSEG (formerly Refinitiv) – Mid-Market
- 4th – U.S. Target Mid-Market (up to $500M)
- 8th – Global Mid-Market (up to $500M)
LSEG (formerly Refinitiv) – Small-Cap
- 3rd – U.S. Target Small-Cap (up to $50M)
- 7th – Global Small-Cap (up to $50M)
Bloomberg – Global M&A
- 5th – U.S. Announced
- 6th – Global Announced
Bloomberg – Mid-Market M&A
- 4th – U.S. Mid-Market (up to $500M)
- 4th – U.S. Mid-Market (up to $250M)
- 6th – Global Mid-Market (up to $500M)
- 6th – Global Mid-Market (up to $250M)
- 12th – Global Private Equity (up to $250M)
Key M&A transactions that Holland & Knight handled in 2023 include: Heartwood Partners' Sale of High Bar Brands; Jim Koons Automotive Companies' $1.2 Billion Sale to Asbury Automotive Group; Oben Holding Group's $116 Million Purchase of Terphane from Tredegar Corp.; and United Western Group's Recapitalization of Veridian Healthcare.